Saba Fooladi

Dec 6, 2024 | cell.com | Jinkyu Park |Muhammad Riaz |Lingfeng Qin |Wei Zhang |Saba Fooladi |Mehmet Kural | +26 more

Keywordsendothelial cellhuman induced pluripotent stem cellsingle ventricle congenital heart defecttissue-engineered vascular conduitflow bioreactorshear stress trainingGet full text accessLog in, subscribe or purchase for full access. References1. de Leval, M.R. ∙ Deanfield, J.E.Four decades of Fontan palliationNat. Rev. Cardiol. 2010; 7:520-5272. Hoffman, J.I.E. ∙ Kaplan, S. The incidence of congenital heart diseaseJ. Am. Coll. Cardiol. 2002; 39:1890-19003. Samánek, M.

Oct 18, 2023 | pubs.rsc.org | Saba Fooladi |Navid Rabiee |Siavash Iravani

Genetically Engineered Bacteria: A New frontier in Targeted Drug Delivery Genetically engineered bacteria (GEB) have shown significant promises to revolutionize modern medicine. These engineered bacteria with unique properties such as enhanced targeting, versatility, biofilm disruption, reduced drug resistance, self-amplification capabilities, and biodegradability represent a highly promising approach for targeted drug delivery and cancer theranostics.

Jun 2, 2023 | pubmed.ncbi.nlm.nih.gov | Nematollahi MH |Saba Fooladi |Mohammad Hadi Nematollahi |Siavash Iravani

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software